Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


David Ridley

Senior Editor – Europe

During his time at OTC bulletin, David focused mainly on the European OTC market, especially German-speaking countries: Germany, Austria and Switzerland). David is interested in European OTC, herbal/homeopathic, food supplement and self-care medical device regulation, and prescription-to-OTC switches in particular. Before working for OTC bulletin, David was a Lecturer in English and Journalism, and alongside his job David moonlights as a musician in a heavy metal band.
Set Alert for Articles By David Ridley

Latest From David Ridley

Switzerland Provides Gateway Into Mainland Europe For BASF’s Hepacor

With the Swiss launch of its Non-Alcoholic Fatty Liver Disease supplement, BASF is looking to make inroads into continental Europe. 
Wellness Dietary Supplements

Majority Of Spanish OTC Firms Investing Heavily In Digital

A recent ANEFP survey shows that the majority of Spanish OTC firms consider their digital strategies to be "very advanced."
Health OTC Drugs

Novartis Seeks 'Amicable' Resolution Of German Probiotics Dispute

Novartis is in discussion via its Hexal subsidiary with Germany's Association for Social Competition (VSW) over whether it must withdraw its Biosan range of probiotic supplements currently on the German market following a recent Higher Regional Court ruling. 
Wellness Dietary Supplements

UK Women’s Health Professionals Join Growing Movement For OTC Oral Contraceptives

The UK's Royal College of Obstetricians and Gynaecologists joins a steadily loudening chorus of organizations calling for the prescription-to-OTC switch of oral contraceptives. 
Health OTC Drugs

Self-Care Medical Devices One Step Closer To Four-Year MDR Extension

Members of the European Parliament will soon decide whether to grant self-care medical devices such as nasal sprays and throat lozenges the same four-year extension as high-risk devices under the new EU Medical Devices Regulation implementation rules. 
Health OTC Drugs

Prescription-To-OTC Switch Of Daily Contraceptives And High-Dose Statins In The UK?

Daily contraceptives and high-dose statins are two OTC categories that have future switch potential, according to UK self-care industry association CEO John Smith. 

Health OTC Drugs
See All